A Study of CDX-585 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Primary Peritoneal Carcinoma
Related studies linked through entity extraction aliases.
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy
- Status
- RECRUITING
- Phase
- PHASE2
ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
- Status
- RECRUITING
- Phase
- NA
A Study to Investigate LYL797 in Adults With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer
- Status
- RECRUITING
- Phase
- NA
A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Combination of ATX-101 and Platinum-based Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2